Evidence map›Paper›PMID 35788590›Full record

ArticleNature communications2022

Clonal barcoding with qPCR detection enables live cell functional analyses for cancer research.

Qiuchen Guo, Milos Spasic, Adam G Maynard, Gregory J Goreczny, Amanuel Bizuayehu, Jessica F Olive, Peter van Galen, Sandra S McAllister

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Qiuchen Guo *Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Milos Spasic *Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Adam G Maynard *Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Gregory J Goreczny *Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Amanuel BizuayehuDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Jessica F OliveDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Peter van GalenDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.ORCID 0000-0002-0735-1570
Sandra S McAllisterDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. smcallister1@bwh.harvard.edu.ORCID 0000-0002-5111-5903
Brigham and Women's Hospital · USBroad Institute · USHarvard University · US

Funding

Understanding How Breast Cancers Activate and Respond to the Systemic EnvironmentR01CA166284 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MCALLISTER, SANDRA S · 2012 to 2018
$2.2M
NCI NIH HHS R01 CA166284
6 · The paper itself

Abstract

Single-cell analysis methods are valuable tools; however, current approaches do not easily enable live cell retrieval. That is a particular issue when further study of cells that were eliminated during experimentation could provide critical information. We report a clonal molecular barcoding method, called SunCatcher, that enables longitudinal tracking and live cell functional analysis. From complex cell populations, we generate single cell-derived clonal populations, infect each with a unique molecular barcode, and retain stocks of individual barcoded clones (BCs). We develop quantitative PCR-based and next-generation sequencing methods that we employ to identify and quantify BCs in vitro and in vivo. We apply SunCatcher to various breast cancer cell lines and combine respective BCs to create versions of the original cell lines. While the heterogeneous BC pools reproduce their original parental cell line proliferation and tumor progression rates, individual BCs are phenotypically and functionally diverse. Early spontaneous metastases can also be identified and quantified. SunCatcher thus provides a rapid and sensitive approach for studying live single-cell clones and clonal evolution, and performing functional analyses.

Indexed as

High-Throughput Nucleotide SequencingNeoplasmsCell LineClonal EvolutionClone CellsReal-Time Polymerase Chain Reaction

Identifiers

PMID35788590
PMCPMC9252988
OpenAlexW4283794535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.